March 20, 2025 · Form 4 insider transaction
DSS, INC. bought 200 shares of IMPACT BIOMEDICAL INC at $1.55 per share, a transaction worth $310.00. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc.